RE: DataOption:
What do you mean this study was already done? Sorry if I am missing something but I thought that they still were waiting for protocol approval and had to send back the baboons that were already ordered.
If the study is already done, I agree it is not a big problem (although I would why it was not submitted). I also wonder why Bioniche would say "In the Company's second quarter report, it was noted that the vaccine could be registered in the U.S. later this year, with a milestone target of Q2 to Q3, calendar 2006. Given the additional review by the USDA, this target may have to be adjusted."
Once again, I apologize to BNC if this study is already done. But if it is not done, you guys are a bunch of screw-ups!! DO THE STUDY WITHOUT PROTOCOL APPROVAL!! It is going to take 6 months minimum to place, monitor and report. At the very worst (if they change the protocol), you will have to re-do it at a cost of may be $500K. At the very best, you will save yourself 6 months of time in the regulatory approval. Yes the studies are complicated - so hire a good toxicologist to direct the studies. But just do it.
Once again, this does not bode well for the vaccine or BNC. I've got to think that if it was such a miracle drug, regulatory agencies would not be insisting on these additional trials. It also shows how out of touch BNC is with the regulators - during the last conference call, CEO McRae was practically chastizing Health Canada for not acting like the USDA (i.e., he said it would be approved in the US before Canada because American regulators were not stupid enough to insist on this additional trials). Now who looks stupid, McRae?!!!
Really losing confidence in this bunch...